Initial Results Comparing High-Resolution Micro-Ultrasound with mpMRI for Prostate Cancer Detection
Improving Standard Transrectal Prostate Biopsy Results Using High Resolution Micro-Ultrasound Real-Time Targeting for Suspicious Areas
A Prospective Validation of the Diagnostic Accuracy of PRI-MUSTM for Prostate Cancer Risk Identification
Initial Clinical Experience with 29 MHz Micro-Ultrasound for Real-Time Targeted Prostate Biopsies
Risk Stratification for Equivocal PI-RADS™ 3 Results: Can Micro-Ultrasound Help Determine Which Men to Biopsy?

Comparison of Micro-Ultrasound and Multiparametric MRI Imaging for Prostate Cancer: International Meta-Analysis
Accuracy of Micro-Ultrasound for Identification of Prostate Cancer: A Comparative Study with Whole Mount Pathology


About Exact Imaging:
Exact Imaging is the world's leader in high-resolution micro-ultrasound systems enabling real-time imaging and guided biopsies in the urological market for prostate cancer. Exact Imaging's ExactVu™ micro-ultrasound platform operates at 29 MHz and enables a whole new level of resolution with the benefits of ease of use, affordability, and is an extension of the current urological workflow. Using the Exact Imaging platform, urologists are able to visualize areas of interest in the prostate and specifically target biopsies at those areas. For those cases where MRI might assist (i.e., prior negative biopsies), the FusionVu™ micro-US/MRI fusion application operates on the ExactVu micro-ultrasound platform and facilitates MRI fusion-based targeting. The ExactVu micro-ultrasound system including the FusionVu application have received regulatory approval in the European Union (CE Mark), the United States (FDA 510(k)) and Canada (Health Canada medical device license).


SOURCE Exact Imaging

Back to HCB News

Ultrasound Homepage